Intellia Therapeutics, Inc. (NASDAQ:NTLA) recently shared significant updates in its 8-K SEC filing, highlighting key financial and strategic changes. The company announced its preliminary financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback